Cellular therapy of cancer symposium December 2nd-3rd 2006 Manchester, UK

Fiona C. Thistlethwaite; David E. Gilham; Robert E. Hawkins

doi:10.1007/s00262-007-0301-8

Cellular therapy of cancer symposium December 2nd-3rd 2006 Manchester, UK

Fiona C. Thistlethwaite
, David E. Gilham
, Robert E. Hawkins

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	939-942
Number of pages	3
Journal	Cancer Immunology, Immunotherapy
Volume	56
Issue number	6
DOIs	https://doi.org/10.1007/s00262-007-0301-8
Publication status	Published - Jun 2007

Keywords

Animals
Clinical Trials
methods: Gene Therapy
Humans
methods: Immunotherapy
immunology: Neoplasms
immunology: T-Lymphocytes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00262-007-0301-8

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17333180

Cite this

@article{e7ebeea17494469ca2110ceaae6f3da9,

title = "Cellular therapy of cancer symposium December 2nd-3rd 2006 Manchester, UK",

keywords = "Animals, Clinical Trials, methods: Gene Therapy, Humans, methods: Immunotherapy, immunology: Neoplasms, immunology: T-Lymphocytes",

author = "Thistlethwaite, \{Fiona C.\} and Gilham, \{David E.\} and Hawkins, \{Robert E.\}",

year = "2007",

month = jun,

doi = "10.1007/s00262-007-0301-8",

language = "English",

volume = "56",

pages = "939--942",

journal = "Cancer Immunology, Immunotherapy",

issn = "0340-7004",

publisher = "Springer Nature",

number = "6",

}

TY - JOUR

T1 - Cellular therapy of cancer symposium December 2nd-3rd 2006 Manchester, UK

AU - Thistlethwaite, Fiona C.

AU - Gilham, David E.

AU - Hawkins, Robert E.

PY - 2007/6

Y1 - 2007/6

KW - Animals

KW - Clinical Trials

KW - methods: Gene Therapy

KW - Humans

KW - methods: Immunotherapy

KW - immunology: Neoplasms

KW - immunology: T-Lymphocytes

U2 - 10.1007/s00262-007-0301-8

DO - 10.1007/s00262-007-0301-8

M3 - Article

SN - 0340-7004

VL - 56

SP - 939

EP - 942

JO - Cancer Immunology, Immunotherapy

JF - Cancer Immunology, Immunotherapy

IS - 6

ER -